Heron Therapeutics, Inc. Stock Deutsche Boerse AG
Stocks
AXD2
US4277461020
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:03:12 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 0.2602 EUR | -2.25% |
|
-9.34% | -76.17% |
| 08-11 | HC Wainwright Downgrades Heron Therapeutics to Neutral From Buy | MT |
| 08-10 | Heron Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 60.41M 51.75M 48.42M 44.32M 83.18M 5.78B 84.28M 572M 223M 2.9B 227M 222M 9.6B | P/E 2026 * |
-2.45x | P/E 2027 * | -2.89x |
|---|---|---|---|---|---|
| Enterprise Value | 60.41M 51.75M 48.42M 44.32M 83.18M 5.78B 84.28M 572M 223M 2.9B 227M 222M 9.6B | EV / Sales 2026 * |
0.41x | EV / Sales 2027 * | 0.41x |
| Free-Float |
99.02% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Heron Therapeutics, Inc.
| 1 day | -2.25% | ||
| 1 week | -9.34% | ||
| Current month | -39.29% | ||
| 1 month | -35.72% | ||
| 3 months | -65.03% | ||
| 6 months | -73.39% | ||
| Current year | -76.17% |
| 1 week | 0.26 |  | 0.28 |
| 1 month | 0.26 | | 0.44 |
| Current year | 0.26 | | 1.29 |
| 1 year | 0.26 | | 1.29 |
| 3 years | 0.26 | | 3.46 |
| 5 years | 0.26 | | 10.8 |
| 10 years | 0.26 | | 36.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 60 | 2023-04-02 |
Ira Duarte
DFI | Director of Finance/CFO | 57 | 2023-06-15 |
Kevin Warner
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Collard
BRD | Director/Board Member | 60 | 2023-02-20 |
Craig Johnson
BRD | Director/Board Member | 64 | 2014-01-12 |
Christian Waage
BRD | Director/Board Member | 59 | 2016-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.25% | -9.34% | - | - | 60.41M | |
| -3.00% | +2.27% | +73.26% | +113.08% | 72.12B | |
| +1.90% | +23.53% | +59.48% | +94.94% | 65.85B | |
| +5.12% | +25.22% | +5.13% | -5.23% | 29.28B | |
| +0.55% | +1.64% | -4.63% | +469.35% | 27.47B | |
| -4.00% | +6.24% | +47.36% | +9.96% | 26.7B | |
| +0.47% | +6.12% | +37.01% | -16.17% | 20.06B | |
| +1.82% | -6.67% | +251.36% | +388.91% | 18.22B | |
| -2.42% | +1.24% | +12.60% | +557.14% | 16.4B | |
| +0.73% | +5.54% | +39.99% | +148.64% | 13.4B | |
| Average | -0.02% | +8.36% | +57.95% | +195.63% | 32.17B | |
| Weighted average by Cap. | -0.01% | +9.48% | +57.17% | +156.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 148M 127M 119M 109M 204M 14.18B 207M 1.4B 547M 7.13B 557M 545M 23.57B | 146M 125M 117M 107M 201M 13.96B 204M 1.38B 539M 7.01B 548M 536M 23.19B |
| Net income | -25M -21.42M -20.04M -18.34M -34.42M -2.39B -34.88M -237M -92.32M -1.2B -93.87M -91.83M -3.97B | -21M -17.99M -16.83M -15.41M -28.92M -2.01B -29.3M -199M -77.55M -1.01B -78.85M -77.14M -3.34B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 26-08-21 | €0.2602 | -2.25% |
| 26-08-20 | €0.2662 | +1.29% |
| 26-08-19 | €0.2628 | -4.58% |
| 26-08-18 | €0.2754 | -4.77% |
| 26-08-17 | €0.2892 | +0.77% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HRTX Stock
- AXD2 Stock
Select your edition
All financial news and data tailored to specific country editions
